Oral Nanomaterials for alternative antibacterial therapy
Despite numerous potent antibiotics, bacterial infections, particularly those caused by nocosomial pathogens are a majorcause of morbidity and mortality around the globe. These affect the severely ill, hospitalized and immunocompromisedpatients who are vulnerable to infections. The option for treatment with antimicrobials is mostly empirical and not bereft oftoxicity, teratogenicity and/or mutagenicity, hypersensitivity. The appearance of multi-drug resistant bacterial strains furtheraggravates the clinical problem as the microorganisms spread epidemically among the patients. Moreover, there is a growingconcern regarding biofilm-associated infections that are refractory to the currently available antimicrobial armory, leavingalmost no treatment option. Thus, there is an urgent need to develop additional bactericidal agents. The attention has beenespecially devoted to new and emerging nanoparticle-based materials in the field of antimicrobial chemotherapy.The past decade has witnessed a substantial surge in the global use of nanomedicines as antimicrobials. Several metaland metal oxide nanoparticles have been reported for their antibacterial activity. The microbes are eradicated either by themicrobicidal effects of the nanoparticles itself, or by microbistatic effects followed by killing potentiated by the host’s immunesystem. The effect of nanoparticles on the microbial biofilms along with the molecular mechanisms by which the nanoparticlesannihilate multidrug-resistant bacteria will be discussed. Combinatorial therapeutic approach with the metallic nanoparticlesmay serve as adjunct to the existing antibiotics and may help to curb the mounting menace of bacterial resistance and nocosomialthreat.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).